pifithrin has been researched along with Alloxan Diabetes in 1 studies
pifithrin: a tetrahydrobenzothiazol; inhibitor of P53 that protects mice from the side effects of cancer therapy; structure in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, J | 1 |
| Liang, W | 1 |
| Tian, Y | 1 |
| Ma, F | 1 |
| Huang, W | 1 |
| Jia, Y | 1 |
| Jiang, Z | 1 |
| Wu, H | 1 |
1 other study available for pifithrin and Alloxan Diabetes
| Article | Year |
|---|---|
Inhibition of P53/miR-34a improves diabetic endothelial dysfunction via activation of SIRT1.
Topics: Animals; Benzothiazoles; Carbazoles; Cells, Cultured; Diabetes Mellitus, Experimental; Endothelial C | 2019 |